Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts

Toxicology Letters

Volumn 220, Issue 2, 2013, Pages 126-134

  Farid, Maha ^a,b,c   Kanaji, Nobuhiro ^a   Nakanishi, Masanori ^a   Gunji, Yoko ^a   Michalski, Joel ^a   Iwasawa, Shunichiro ^a   Ikari, Jun ^a   Wang, Xingqi ^a   Basma, Hesham ^a   Nelson, Amy J ^a   Liu, Xiangde ^a   Rennard, Stephen I ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

Cigarette smoke; Lungs; Smad3; VEGF

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CIGARETTE SMOKE; CIGARETTE SMOKE EXTRACT; NICOTINE; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE; FIBROBLASTS; GENE KNOCKOUT TECHNIQUES; HUMANS; LUNG; NICOTINE; PHOSPHORYLATION; RNA, SMALL INTERFERING; SMAD3 PROTEIN; SMOKE; TOBACCO; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CYPRINIDAE;

EID: 84878994558     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.04.011     Document Type: Article

References (21)

1. Brody H. Chronic obstructive pulmonary disease. Nature 2012, 489(7417):S1.
2. Carnevali S., Nakamura Y., Mio T., Liu X., Takigawa K., Romberger D.J., Spurzem J.R., Rennard S.I. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. The American Journal of Physiology 1998, 274(4 Pt 1):L591-L598.
3. Chang J.S. Parental smoking and childhood leukemia. Methods in Molecular Biology (Clifton N.J.) 2009, 472:103-137.
4. Chen L.J., Zhao Y., Gao S., Chou I.N., Toselli P., Stone P., Li W. Downregulation of lysyl oxidase and upregulation of cellular thiols in rat fetal lung fibroblasts treated with cigarette smoke condensate. Toxicological Sciences: An Official Journal of the Society of Toxicology 2005, 83(2):372-379.
5. Carp H., Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. American Review of Respiratory Disease 1978, 118(3):617-621.
6. Flanders K.C. Smad3 as a mediator of the fibrotic response. International Journal of Experimental Pathology 2004, 85(2):47-64.
7. Kamio K., Sato T., Liu X., Sugiura H., Togo S., Kobayashi T., Kawasaki S., Wang X., Mao L., Ahn Y., Holz O., Magnussen H., Rennard S.I. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture. American Journal of Physiology. Lung Cellular and Molecular Physiology 2008, 294(6):L1226-L1232.
8. Kanazawa H. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2007, 13(11):RA189-RA195.
9. Kobayashi T., Liu X., Wen F.Q., Fang Q., Abe S., Wang X.Q., Hashimoto M., Shen L., Kawasaki S., Kim H.J., Kohyama T., Rennard S.I. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochemical and Biophysical Research Communications 2005, 327(2):393-398.
10. Laurent P., Janoff A., Kagan H.M. Cigarette smoke blocks cross-linking of elastin in vitro. Chest 1983, 83(5 Suppl.):63S-65S.
11. Martinez F.J., Donohue J.F., Rennard S.I. The future of chronic obstructive pulmonary disease treatment - difficulties of and barriers to drug development. Lancet 2011, 378(9795):1027-1037.
12. Mura M., dos Santos C.C., Stewart D., Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. Journal of Applied Physiology (Bethesda, MD: 1985) 2004, 97(5):1605-1617.
13. Nakamura Y., Romberger D.J., Tate L., Ertl R.F., Kawamoto M., Adachi Y., Mio T., Sisson J.H., Spurzem J.R., Rennard S.I. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. American Journal of Respiratory and Critical Care Medicine 1995, 151(5):1497-1503.
14. Nakanishi M., Sato T., Li Y., Nelson A.J., Farid M., Michalski J., Kanaji N., Wang X., Basma H., Patil A., Goraya J., Liu X., Togo S.L., Toews M., Holz O., Muller K.C., Magnussen H., Rennard S.I. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology 2012, 46(2):217-223.
15. Papaioannou A.I., Kostikas K., Kollia P., Gourgoulianis K.I. Clinical implications for vascular endothelial growth factor in the lung: friend or foe?. Respiratory Research 2006, 7:128.
16. Rennard S.I., Wachenfeldt K. Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2011, 8(4):368-375.
17. Rovina N., Papapetropoulos A., Kollintza A., Michailidou M., Simoes D.C., Roussos C., Gratziou C. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?. Respiratory Research 2007, 8:53.
18. Scaffidi A.K., Petrovic N., Moodley Y.P., Fogel-Petrovic M., Kroeger K.M., Seeber R.M., Eidne K.A., Thompson P.J., Knight D.A. alpha(v)beta(3) integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. The Journal of Biological Chemistry 2004, 279(36):37726-37733.
19. Soriano J.B., Lamprecht B. Chronic obstructive pulmonary disease: a worldwide problem. The Medical Clinics of North America 2012, 96(4):671-680.
20. Tam A., Sin D.D. Pathobiologic mechanisms of chronic obstructive pulmonary disease. The Medical Clinics of North America 2012, 96(4):681-698.
21. Wongtrakool C., Roser-Page S., Rivera H.N., Roman J. Nicotine alters lung branching morphogenesis through the alpha7 nicotinic acetylcholine receptor. American Journal of Physiology. Lung Cellular and Molecular Physiology 2007, 293(3):L611-L618.